Global Blood Therapeutics Inc (GBT)

67.48
NASDAQ
Prev Close 69.50
Day Low/High 66.67 / 70.02
52 Wk Low/High 39.95 / 87.54
Exchange NASDAQ
Shares Outstanding 60.94B
Market Cap 4.24B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Markets Get Back to Business as Usual

Markets Get Back to Business as Usual

U.S. stocks move higher after early slip, as investors digest Apple's latest results.

DBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers

DBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers

The Montrouge, France-based firm on Friday unveiled top-line results from its Phase 3 study of a peanut allergy treatment. The study, dubbed Pepites, evaluated Viaskin Peanut in children four to 11 years old.

Global Blood Therapeutics Makes a Bold Move

Global Blood Therapeutics Makes a Bold Move

This stock's old highs may come into play.

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

The major indices barely budged intraday this week, as we had the narrowest trading range ever.

Russell Rebalancing Tops Off a Choppy Week

Russell Rebalancing Tops Off a Choppy Week

It's hard to be too negative considering the speculative action today.

There's No Rush for the Exits So Far

There's No Rush for the Exits So Far

There's lots of negativity, but dip buyers are showing up.

Market Is Home on the Range Again

Market Is Home on the Range Again

Emotion of yesterday's collapse is pretty much gone.

Traders Are Aggressively Fading the Open

Traders Are Aggressively Fading the Open

But what will be most important is whether support stays strong and the buyers show interest in the afternoon.

My Screen Looks Quite Bloody

My Screen Looks Quite Bloody

Not making any new buys, but I haven't rushed to make sales either.

Market Takes 'National Napping Day' Seriously

Market Takes 'National Napping Day' Seriously

U.S. stocks saw slow action ahead of the start of a Fed meeting and a big East Coast snow storm Tuesday.

Biotech Leads the Way Again Today

Biotech Leads the Way Again Today

This group has had some excellent speculative action lately while not much else has been working.

Rev's Forum: Bulls Still Believe, but Negative Catalysts are Building

Rev's Forum: Bulls Still Believe, but Negative Catalysts are Building

The markets' focus will be on the pace of future interest rate hikes.

Late Market Rally but No Bounce for Bulls

Late Market Rally but No Bounce for Bulls

We end the week with the same question we had at the start.

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

Shark Bites: Market Needs a Bounce in Its Step

Shark Bites: Market Needs a Bounce in Its Step

Biotechnology continues to be a bright spot.

Market Set Up for Oversold Bounce

Market Set Up for Oversold Bounce

We'll learn a lot from the market's action today

These Stocks Are Trending Up With Monster Volume

These Stocks Are Trending Up With Monster Volume

Let's take a look at several stocks that are experiencing unusual volume activity.

Is This a Market Top or Just Consolidation?

Is This a Market Top or Just Consolidation?

Afternoon surge is surfacing again.

Market Taking a Break, but Probably Not for Long

Market Taking a Break, but Probably Not for Long

Today is more about stock picking.

Markets Are Selling the Mnuchin News

Markets Are Selling the Mnuchin News

It is clear that tax policy isn't going to be solidified in a couple of weeks.

The Contrary Indicators Are Piling Up

The Contrary Indicators Are Piling Up

But it is all about timing, and so far there is no indication that this extended market is about to turn.

Some Stock Picks on This Morning's Dip

Some Stock Picks on This Morning's Dip

It will be interesting to see today if afternoon strength occurs once again.

Trading in a Rising Market Simply Isn't as Simple as It May Seem

Trading in a Rising Market Simply Isn't as Simple as It May Seem

Finding new buys becomes more difficult, and knowing when to lock in gains isn't easy, either.

Fear of Missing Out Is Building

Fear of Missing Out Is Building

You can feel the misery of those who are struggling with feelings of being left behind.

Rev's Forum: The Fed Isn't Convinced the Trump Rally Is Justified

Rev's Forum: The Fed Isn't Convinced the Trump Rally Is Justified

Its members are skeptical about the market celebration and are not going to commit to a course of rate hikes until they have more data.

Trying to Knock Out Some Individual Trades, but it Is not Easy

Trying to Knock Out Some Individual Trades, but it Is not Easy

If the indices take out yesterday's lows I'll be very bearish very quickly.

7 Low-Priced Stocks to Watch in 2017

7 Low-Priced Stocks to Watch in 2017

Good picks make it easier to produce good results, but they are just a starting point.

Shark Bites: We Knew Today Would Be Slow, but Come On…

Shark Bites: We Knew Today Would Be Slow, but Come On…

Don't force it; there's no energy.

The Market Offers Some Opportunities but They're Disappearing Fast

The Market Offers Some Opportunities but They're Disappearing Fast

The market isn't buying that Trump is bad for business